These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 31905718)
1. Trends, Patient and Prescriber Characteristics in Gabapentinoid Use in a Sample of United States Ambulatory Care Visits from 2003 to 2016. Zhou L; Bhattacharjee S; Kwoh CK; Tighe PJ; Malone DC; Slack M; Wilson DL; Brown JD; Lo-Ciganic WH J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31905718 [TBL] [Abstract][Full Text] [Related]
2. Gabapentinoid misuse, abuse and non-prescribed obtainment in a United States general population sample. Evoy KE; Covvey JR; Peckham AM; Reveles KR Int J Clin Pharm; 2021 Aug; 43(4):1055-1064. PubMed ID: 33387188 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients. Ibiloye EA; Barner JC; Lawson KA; Rascati KL; Evoy KE; Peckham AM Clin Drug Investig; 2021 Mar; 41(3):245-253. PubMed ID: 33580482 [TBL] [Abstract][Full Text] [Related]
5. Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland. Torrance N; Veluchamy A; Zhou Y; Fletcher EH; Moir E; Hebert HL; Donnan PT; Watson J; Colvin LA; Smith BH Br J Anaesth; 2020 Aug; 125(2):159-167. PubMed ID: 32571568 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of Cough Medication Use Patterns in Ambulatory Care Settings in the United States: 2003-2018. Yang S; Hincapie-Castillo JM; Ke X; Schelfhout J; Ding H; Sher MR; Zhou L; Chang CY; Wilson DL; Lo-Ciganic WH J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35806956 [TBL] [Abstract][Full Text] [Related]
7. Trends in Gabapentin and Pregabalin Prescribing in a Tertiary Pediatric Medical Center. Donado C; Nedeljkovic K; Wangnamthip S; Solodiuk JC; Bourgeois FT; Berde CB Hosp Pediatr; 2021 Aug; 11(8):909-914. PubMed ID: 34257145 [TBL] [Abstract][Full Text] [Related]
8. Pharmacist, prescriber, and drug policy expert opinions on gabapentinoid misuse. Covvey JR; Blakely ML; Singh R; Peckham AM; Evoy KE Res Social Adm Pharm; 2023 Apr; 19(4):599-609. PubMed ID: 36503683 [TBL] [Abstract][Full Text] [Related]
10. Trends in Prescribing of Non-steroidal Anti-inflammatory Medications in the US Ambulatory Care Setting From 2006 to 2016. Keshwani S; Smith SM; Brown J; Lo-Ciganic WH; Yang S; Smolinski NE; Hincapie-Castillo JM J Pain; 2023 Nov; 24(11):1994-2002. PubMed ID: 37330160 [TBL] [Abstract][Full Text] [Related]
11. Gabapentinoids in Ireland 2010 to 2020: An observational study of trends in gabapentinoid prescribing, law enforcement drug seizures and postmortem toxicology. Durand L; O'Kane A; Tierney J; Cronly M; Bennett KE; Kavanagh Y; Keenan E; Cousins G Br J Clin Pharmacol; 2024 Apr; 90(4):987-995. PubMed ID: 38072974 [TBL] [Abstract][Full Text] [Related]
13. Trends in gabapentinoid prescribing in patients with osteoarthritis: a United Kingdom national cohort study in primary care. Appleyard T; Ashworth J; Bedson J; Yu D; Peat G Osteoarthritis Cartilage; 2019 Oct; 27(10):1437-1444. PubMed ID: 31276819 [TBL] [Abstract][Full Text] [Related]
14. Use of gabapentinoid medications among US adults with cancer, 2005-2015. Fauer AJ; Davis MA; Choi SW; Wallner LP; Friese CR Support Care Cancer; 2020 Jan; 28(1):5-8. PubMed ID: 31650294 [TBL] [Abstract][Full Text] [Related]
15. Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth. McAnally H; Bonnet U; Kaye AD Pain Ther; 2020 Dec; 9(2):441-452. PubMed ID: 32737803 [TBL] [Abstract][Full Text] [Related]
16. Trends in gabapentinoid prescribing in UK primary care using the Clinical Practice Research Datalink: an observational study. Ashworth J; Bajpai R; Muller S; Bailey J; Helliwell T; Harrisson SA; Whittle R; Mallen CD Lancet Reg Health Eur; 2023 Apr; 27():100579. PubMed ID: 37069852 [TBL] [Abstract][Full Text] [Related]
17. Fatalities associated with gabapentinoids in England (2004-2020). Kalk NJ; Chiu CT; Sadoughi R; Baho H; Williams BD; Taylor D; Copeland CS Br J Clin Pharmacol; 2022 Aug; 88(8):3911-3917. PubMed ID: 35435281 [TBL] [Abstract][Full Text] [Related]
18. Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update. Evoy KE; Sadrameli S; Contreras J; Covvey JR; Peckham AM; Morrison MD Drugs; 2021 Jan; 81(1):125-156. PubMed ID: 33215352 [TBL] [Abstract][Full Text] [Related]
19. Intentional Drug Overdose Involving Pregabalin and Gabapentin: Findings from the National Self-Harm Registry Ireland, 2007-2015. Daly C; Griffin E; Ashcroft DM; Webb RT; Perry IJ; Arensman E Clin Drug Investig; 2018 Apr; 38(4):373-380. PubMed ID: 29264838 [TBL] [Abstract][Full Text] [Related]
20. Outpatient Off-Label Gabapentin Use for Psychiatric Indications Among U.S. Adults, 2011-2016. Costales B; Goodin AJ Psychiatr Serv; 2021 Nov; 72(11):1246-1253. PubMed ID: 34015964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]